GeneDx Holdings Corp. (WGS)

USD 76.93

(-2.87%)

Market Cap (In USD)

2.11 Billion

Revenue (In USD)

202.56 Million

Net Income (In USD)

-175.76 Million

Avg. Volume

454.17 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
2.466-89.11
PE
-
EPS
-
Beta Value
2.18
ISIN
US81663L2007
CUSIP
81663L200
CIK
1818331
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Ms. Katherine A. Stueland
Employee Count
-
Website
http://www.genedx.com
Ipo Date
2020-11-04
Details
GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.